Source: https://www.fr.com/cases/recent-litigation-examples/
Timestamp: 2019-04-26 04:06:32+00:00

Document:
Allergan, Inc. v. Sandoz Inc. et al. (E.D. Tex.) – representing Plaintiff Allergan in Hatch-Waxman litigation against four separate generic drug manufacturers regarding their ANDAs seeking to market generic versions of Allergan’s glaucoma drug, LUMIGAN® 0.01%.
CyberFone Systems, LLC v. Amazon.com, Inc, et al. (D. Del.) – representing multiple defendants in litigation on patents related to communications by handheld devices. Secured early summary judgment of patent invalidity under 35 U.S.C. 101.
Parallel Networks, LLC v. Backstage Web. Inc., et al. (D. Del. and E.D. Tex.) – representing four defendants in patent litigation related to patents regarding internet transactions. Argued and won motion to transfer before the Judicial Panel on Multidistrict Litigation, obtaining transfer of case to the Eastern District of Texas.
W.L. Gore & Assoc., Inc. v. Medtronic, Inc., et al. (E.D. Va.) — representing plaintiff W.L. Gore in case relating to intraluminal stent grafts.
Allergan, Inc. v. Sandoz., Inc., et al. (E.D. Tex.) – representing Plaintiff Allergan in Hatch-Waxman litigation against five generic drug manufacturers regarding Allergan’s glaucoma drug, COMBIGAN®. Won judgment of infringement and validity on all four patents-in-suit after bench trial.
Eurand, Inc., et al. v. Mylan Pharms., Inc., et al. (D. Del.) – representing Plaintiffs in Hatch-Waxman litigation on patents related to the skeletal muscle relaxant AMRIX®. Won judgment of infringement and validity against first-filer Mylan at the Federal Circuit on two patents.
In re Brimonidine Patent Litigation (D. Del.) – counsel for Allergan in multi-district litigation regarding multiple ANDAs for Allergan’s glaucoma drugs ALPHAGAN P 0.15% and ALPHAGAN P 0.1%. Verdict of infringement, validity and enforceability on all five patents-in-suit.

References: v. 
 v. 
 v. 
 v. 
 v. 
 v.